LAM Therapeutics Announces Close of $58M Series C Financing and New Clinical Program in …

LAM accelerates drug development by integrating genomics and proteomics technologies with deep learning artificial intelligence (AI) to match clinical …

Link to Full Article

[Link to Full Article]

Pin It on Pinterest

Share This